Technology > Plastic-based Arrays
Akonni’s proprietary gel-drop microarrays have been shown to be amenable to a plastic substrate, instead of a traditional glass slide. The unique co-polymerization methodology can be implemented on unmodified, off-the-shelf plastic polymers, which eliminates the need for high-priced glass slides and surface treatments, allowing for a 1,000x lower costs of goods.
The advantage of printing on unmodified plastic, combined with the valve-less microfluidic approach (see ‘Integrated Microfluidic Microarray Consumable’ section), offers the potential to manufacture the Akonni TruArrays in a reel-to-reel format. Reel-to-reel manufacturing could conceivably reduce the cost by one to two orders of magnitude as compared with traditional microfluidic cartridges.
Reel-to-reel assembly is a method of high volume production used predominantly for the assembly of lateral flow strips and flexible film electronics. The virtue of this manufacturing method is that high volume production can be very cost effective. Using standard production equipment, assembly of the devices can be completely automated at very high speeds. In fact, lateral flow strips, manufactured in this reel-to-reel format, often cost less than a dollar.
© 2003-2025 Akonni Biosystems, Inc. All rights reserved. Terms and Conditions • Privacy Policy
TruDiagnosis Systems, TruDx Readers, TruArray Tests, TruTip Kits, Primers, Lysis and Binding Buffers, Wash Buffers and Elution Buffers: For Research Use Only. Not for use in diagnostic procedures. No claim or representation is intended to provide information for the diagnosis, prevention or treatment of a disease.
Based on its recent analysis of the microarrays in molecular diagnostics (MDx) market, Frost & Sullivan recognizes Akonni Biosystems with the 2017 North American New Product Innovation Award.
Akonni’s integrated MDx system, TruDiagnosis®, is revolutionizing the point-of-care molecular testing market by enabling target detection from a variety of sample types. TruDiagnosis® is powered by TruArray®, a patented 3D gel-drop microarray technology for sample screening that instantly indicates the presence of disease markers in real time.
Download: